SMG1 and neoplasm: As the BRCA study [21] included the detailed scRNAseq immune dataset, we performed a precise analysis of the different T-cell subpopulations after dimensional reduction (UMAP) and separation in the group of patients based on low SMG1 and high SMG1 expression in the tumor cells.